PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752 · cited 5×
“A growing body of literature suggests that one of the consequences of genetic instability in cancer is the presence of aberrant nucleic acids in the cytosol (Paludan et al., 2019; Hatch et al., 2013; Harding et al., 2017; Mackenzie et al., 2017; Gluck et al., 2017).”
BackgroundInfluentialCorrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Harding, S. M., Benci, J. L., Irianto, J., Discher, D. E., Minn, A. J., & Greenberg, R. A. (2017) · Nature · doi:10.1038/nature23470 · Cited by 1,508
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313 · cited 3×
“…sensing mechanisms through cGAS/STING and RIG-I, activate type I IFNs to induce innate immunity in response to pathogenor damage-generated cytosolic nucleic acids (Ivashkiv and Donlin, 2014; Paludan et al., 2019; Barber, 2015; Ishikawa and Barber, 2008; Ahn et al., 2014; Hartlova et al., 2015).”
BackgroundType I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Glück, S., Guey, B., Gulen, M. F., Wolter, K., Kang, T.-W., Schmacke, N. A., Bridgeman, A., Rehwinkel, J., Zender, L., & Ablasser, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3586 · Cited by 1,196 · cited 5×
“A growing body of literature suggests that one of the consequences of genetic instability in cancer is the presence of aberrant nucleic acids in the cytosol (Paludan et al., 2019; Hatch et al., 2013; Harding et al., 2017; Mackenzie et al., 2017; Gluck et al., 2017).”
BackgroundInfluential
Cited by
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Metadata
- Authors
- Gozgit, J. M., Vasbinder, M. M., Abo, R. P., Kunii, K., Kuplast-Barr, K. G., Gui, B., Lu, A. Z., Molina, J. R., Minissale, E., Swinger, K. K., Wigle, T. J., Blackwell, D. J., Majer, C. R., Ren, Y., Niepel, M., Varsamis, Z. A., Nayak, S. P., Bamberg, E., Mo, J.-R., Church, W. D., Mady, A. S. A., Song, J., Utley, L., Rao, P. E., Mitchison, T. J., Kuntz, K. W., Richon, V. M., & Keilhack, H.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 39
- Issue
- 9
- Pages
- 1214-1226.e10
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3186610389
- Cited by
- 181
- References
- 19
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. https://app.cochat.ai/papers/10.1016/j.ccell.2021.06.018
- The paper
- Gozgit, J. M., Vasbinder, M. M., Abo, R. P., Kunii, K., Kuplast-Barr, K. G., Gui, B., Lu, A. Z., Molina, J. R., Minissale, E., Swinger, K. K., Wigle, T. J., Blackwell, D. J., Majer, C. R., Ren, Y., Niepel, M., Varsamis, Z. A., Nayak, S. P., Bamberg, E., Mo, J.-R., . . . Keilhack, H. (2021). PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. Cancer Cell. https://doi.org/10.1016/j.ccell.2021.06.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.